Catalyst
Slingshot members are tracking this event:
PDUFA date of October 6, 2018 announced for Ionis'(IONS) Inotersen in hereditary TTR amyloidosis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| IONS | Community voting in process | |||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 05, 2018
Occurred Source:
http://ir.ionispharma.com/news-releases/news-release-details/akcea-and-ionis-receive-fda-approval-tegseditm-inotersen
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Hereditary Attr Amyloidosis, Inotersen
